Best Immunotherapy for prostate cancer Doctors Abroad for Australian Patients

Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.

• Authored over 40 research publications focusing on tumor biology and immunology.
• Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
• Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
• Member of the Turkish Medical Oncology Association and European Head and Neck Society.

Professor Mustafa Solak gained international expertise at the University of Texas MD Anderson Cancer Center, world-renowned for developing modern cancer protocols.

• Specialises in immunotherapy with Keytruda for advanced prostate malignancies
• Completed an advanced oncology fellowship at the Hacettepe University Cancer Institute
• Integrates hormone therapy and targeted treatments for systemic cancer care
• Treats complex solid tumours at Hisar Hospital Intercontinental in Istanbul
• Expertise includes managing side effects of modern biological therapies

Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.

• Served as the head of the medical oncology unit at Haydarpaşa Numune Hospital.
• Participated in global training at Oxford University and ESMO in Manchester.
• Treats gastrointestinal, urological, lung, and breast cancers.
• Member of the American and European Societies of Medical Oncology.

Professor Sezer Sağlam is a senior medical oncologist at Gayrettepe Florence Nightingale Hospital, specialising in complex systemic therapies for advanced malignancies.

• Holds a professorship in medical oncology – the highest academic rank in the field
• Maintains active membership in the American Society of Clinical Oncology (ASCO)
• Member of the European Society for Medical Oncology (ESMO)
• Specialised in neuroendocrine tumours through the European Neuroendocrine Tumour Society (ENET)
• Fellowship trained at Istanbul University – Turkey's most prestigious medical institution

Dr. Abdullah Sakin is a medical oncologist at Medipol Bahçelievler University Hospital in Istanbul. He specializes in treating complex cancers, including lung, breast, and gastrointestinal malignancies. Dr. Sakin previously served as the Head of the Medical Oncology Department at Yüzüncü Yıl University. He also held a leadership role at Prof. Dr. Cemil Taşçıoğlu City Hospital.

• Provides immunotherapy, biological therapy, and hormone treatments for various cancer types.
• Treats rare and difficult conditions like thymoma, chordoma, and Ewing's sarcoma.
• Performs PET-CT scans and comprehensive oncological check-ups for men and women.
• Uses JCI-accredited facilities with systems like TrueBeam STx and Halcyon for treatment.

Professor Karaaslan leads systemic cancer treatments at Anadolu Medical Center, an institution affiliated with the world-renowned Johns Hopkins Medicine.

• Specialises in immunotherapy and targeted therapy for urogenital cancers
• Combines hormone therapy with modern systemic protocols for prostate cases
• Former oncology expert at the Gülhane Military Medical Academy
• Active member of the Turkish Medical Oncology Society
• Trained at Istanbul University’s prestigious medical faculties

Dr. Yesim Yildirim is a medical oncologist at Anadolu Medical Center. She specializes in immunotherapy and targeted therapy for breast, lung, and gastrointestinal cancers. Dr. Yildirim is ESMO-certified and holds the rank of Professor. She completed training at Mount Vernon in the UK and Rambam Medical Center.

• Authored over 80 scientific publications on tumor biology and precision medicine.
• Treats complex cases including melanoma, sarcomas, and stage 4 lung cancer.
• Member of ASCO and the International Society of Gastrointestinal Oncology.
• Works at Anadolu Medical Center, an affiliate of Johns Hopkins Hospital.

Dr. Seref Komurcu is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, lung, colorectal, and solid cancers. Dr. Komurcu holds both ECFMG and ESMO certifications. He previously served as a professor at Gülhane Military Medical Academy.

• Published over 110 scientific papers on cancer management.
• Provides immunotherapy, targeted therapy, and chemotherapy treatments.
• Member of the American Society of Clinical Oncology.
• Works at a clinic affiliated with Johns Hopkins Medicine.

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.

The doctor is an oncologist specializing in the treatment of breast, lung, and gastrointestinal cancers. Currently, the doctor practices at Istinye Liv University Hospital.

With a career spanning multiple esteemed institutions, the doctor has served as an Internal Medicine Specialist at Malatya State Hospital, a physician at Ankara Oncology Clinic, and a member of the Oncology Department at Erzurum Regional Training and Research Hospital.

The doctor graduated from the Faculty of Medicine at Selcuk University and achieved the title of Associate Professor in 2016.

Professor Cemil Bilir is a leading medical oncologist specialising in molecular oncology and the latest immunotherapy protocols for urological cancers.

• Completed a research fellowship at Northeastern University's Center for Pharmaceutical Biotechnology and Nanomedicine in Boston
• Serves as a Professor at Sakarya University Faculty of Medicine – one of Turkey's established medical schools
• Active member of the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO)
• Participates in international clinical trials to provide patients with emerging cancer therapies

Associate Professor Nail Paksoy is a dual-certified specialist in both immunology and medical oncology, offering a unique perspective on immunotherapy treatments. He currently serves at Medipol Bahcelievler University Hospital in Istanbul.

• Holds ESMO Board Certification in Medical Oncology from Paris
• Completed a dedicated fellowship in Allergy and Immunology
• Published research on PSMA-based tumour burden and immunotherapy outcomes
• Serves as a sub-investigator for major international clinical trials with Roche and MSD

Professor Irfan Cicin is a senior medical oncologist who leads the oncology department at Trakya University Faculty of Medicine. He specialises in systemic treatments for complex urological cancers at İstinye University Liv Hospital Topkapı.

• Holds a full professorship in oncology, training the next generation of cancer specialists
• Completed senior fellowship training in medical oncology at Trakya University
• Published extensive research on medical oncology protocols and internal medicine
• Member of the Turkish Society of Medical Oncology

Associate Professor Muhammed Mustafa Atci is a highly regarded medical oncologist at İstinye University Liv Hospital Topkapı, where he specialises in advanced cancer protocols.

• Holds a dual specialty in internal medicine and medical oncology with a focus on modern targeted therapies
• Acts as an Education Coordinator, training the next generation of oncology specialists in Turkey
• Active member of the American Society of Clinical Oncology (ASCO) since 2018
• Extensively published in peer-reviewed international journals on tumour biomarkers and survival outcomes